Skin Testing in Fixed Drug Eruptions: A Useful and Safe Tool?

Affiliations

¹ Department of Respiratory Medicine & Allergy, Homerton Healthcare NHS Foundation Trust, London, United Kingdom.
² Department of Respiratory Medicine & Allergy, Homerton Healthcare NHS Foundation Trust, London, United Kingdom; National Heart & Lung Institute, Imperial College London, London, United Kingdom. Electronic address: t.watts@imperial.ac.uk.

Editorial

Joseph Jayasundera et al. J Allergy Clin Immunol Pract. 2024 Feb.

. 2024 Feb;12(2):469-471.

doi: 10.1016/j.jaip.2023.11.033.

¹ Department of Respiratory Medicine & Allergy, Homerton Healthcare NHS Foundation Trust, London, United Kingdom.
² Department of Respiratory Medicine & Allergy, Homerton Healthcare NHS Foundation Trust, London, United Kingdom; National Heart & Lung Institute, Imperial College London, London, United Kingdom. Electronic address: t.watts@imperial.ac.uk.

No abstract available

Comment on

In Situ Patch Test and Repeated Open Application Test for Fixed Drug Eruption: A Multicenter Study.
Traineau H, Milpied B, Soria A, Assier H, Tetart F, Bernier C, Le Bouëdec MF, Gener G, Kurihara F, Bauvin O, Delauney J, Amsler E, Bara C, Pelletier F, Valois A, Castelain F, de Risi Pugliese T, Hamelin A, Barbaud A. Traineau H, et al. J Allergy Clin Immunol Pract. 2024 Feb;12(2):460-468. doi: 10.1016/j.jaip.2023.10.021. Epub 2023 Oct 19. J Allergy Clin Immunol Pract. 2024. PMID: 37863314